TGO 92 impacts on product name presentation

The new labelling legislation states that, as per TGO 92, ‘The name of the medicine on the main label must be presented in a continuous, uninterrupted manner and not be broken up by additional information or background text’.

Where the name of the medicine means the following:

(a) where the medicine is intended to be, or is, entered in the Register – the name of the medicine intended to appear or appearing on the Certificate of Registration or Certificate of Listing in relation to the medicinenot including the following information: